Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). AFT Pharmaceuticals's share price for the quarter that ended in Mar. 2026 was NZ$3.36. AFT Pharmaceuticals's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 104.9 Mil. Therefore, AFT Pharmaceuticals's market cap for the quarter that ended in Mar. 2026 was NZ$352.3 Mil.
AFT Pharmaceuticals's quarterly market cap
increased
from Mar. 2025 (NZ$282.1 Mil) to Sep. 2025 (NZ$292.6 Mil) and
increased
from Sep. 2025 (NZ$292.6 Mil) to Mar. 2026 (NZ$352.3 Mil).
AFT Pharmaceuticals's annual market cap
declined
from Mar. 2024 (NZ$328.2 Mil) to Mar. 2025 (NZ$282.1 Mil) but then
increased
from Mar. 2025 (NZ$282.1 Mil) to Mar. 2026 (NZ$352.3 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. AFT Pharmaceuticals's Enterprise Value for Today is NZ$452.7 Mil.
AFT Pharmaceuticals (NZSE:AFT) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
AFT Pharmaceuticals Market Cap Related Terms
AFT Pharmaceuticals Market Cap Historical Data
* Premium members only.
The historical data trend for AFT Pharmaceuticals's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NZSE:AFT vs ZTS, UTHR, VTRS: Market Cap Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, AFT Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AFT Pharmaceuticals Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, AFT Pharmaceuticals's Market Cap distribution charts can be found below:
* The bar in red indicates where AFT Pharmaceuticals's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
AFT Pharmaceuticals's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AFT Pharmaceuticals (NZSE:AFT) has a Market Cap of NZ$410.0 Mil as of Jul. 12, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on AFT Pharmaceuticals and its competitors. According to the industry distribution chart, AFT Pharmaceuticals ranks #507 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 49.5%.
Is AFT Pharmaceuticals' Market Cap too high?
AFT Pharmaceuticals' current Market Cap is NZ$410.0 Mil. Based on the distribution chart, AFT Pharmaceuticals ranks #507 out of 1024 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, AFT Pharmaceuticals has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does AFT Pharmaceuticals' Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, AFT Pharmaceuticals ranks #507 out of 1024 companies for Market Cap. This puts AFT Pharmaceuticals in the upper half of its industry. The industry median Market Cap is 213.52. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 213.52, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on AFT Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Market Cap is 213.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AFT Pharmaceuticals's current Market Cap is NZ$410.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AFT Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, AFT Pharmaceuticals (NZSE:AFT) is currently considered Fairly Valued. The stock's GF Value™ is NZ$4.18, compared to a current price of NZ$3.91 — trading 6.5% below its estimated fair value. The current Market Cap is NZ$410.0 Mil. AFT Pharmaceuticals' overall GF Score™ is 95/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For AFT Pharmaceuticals (NZSE:AFT), the current Market Cap is NZ$410.0 Mil as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AFT Pharmaceuticals (NZSE:AFT) Overvalued in 2026?
Based on GuruFocus' analysis, AFT Pharmaceuticals stock appears to be undervalued.
The current stock price of NZ$3.91 is trading 6.5% below its estimated GF Value™ of NZ$4.18.
GuruFocus considers AFT Pharmaceuticals to be Fairly Valued.
Key valuation signals for NZSE:AFT:
Market Cap: NZ$410.0 Mil
GF Value™: NZ$4.18 vs. price of NZ$3.91 (6.5% below fair value)
No single metric tells the full story. See the NZSE:AFT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Maxigesic dose forms, Capsaicin creams, Crystaderm, Kiwisoothe, Micolette, and others. The group has four operating segments based on geographical location being Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia, which includes the sales and distribution activity relating to the Australian market.
95GF Score
Get the complete analysis for NZSE:AFT
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NZSE:AFT has been successfully added to your 
